AFS SC
36.9 FTEThe score of AFS shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +20 % Equity +7 % Total assets +14 % Headcount (avg FTE) -9 %
Accounts of the company itself (not consolidated).
The full file covers 15 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AFS's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €9.02m | ||||
| Net result | 274,052 € | ||||
| Equity | €10.8m | ||||
| Cash | 290,300 € | ||||
| EBITDA | 625,553 € | ||||
| Total assets | €22.0m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 May 2026
- Year ended 31 Dec 2024filed on 16 May 2025
- Year ended 31 Dec 2023filed on 29 May 2024
- Year ended 31 Dec 2022filed on 31 May 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
AFS's financial analysis
- Solvency49.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AFS
AFS's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0406.383.082
- VAT number
- BE0406383082
- Peppol
- Registered · 0208:0406383082 · as of 10 Nov 2026
- Legal form
- SC
- Incorporated
- 13 May 1968
- Registered office
- 2600 Antwerp
- Size
- Small · 36.9 FTE
- Latest accounts
- 2025 · filed on 22 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
AFS (SC) has been based in Antwerp since 1968, active in: retail sale of pharmaceutical products. For 2025, it reports revenue of €9.02m, a net profit of 274,052 € and equity of €10.8m. With 36.9 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 49.2%, above the median of its sector (44.2%).
Companies similar to AFS
Companies in the same business, of comparable size and area, outside its group.
- Coop-Apotheken Retail sale of pharmaceutical products Ghent · balance sheet €31.2m
- Vooruit NR. 1 Retail sale of pharmaceutical products Ghent · balance sheet €18.3m
- MOES Retail sale of pharmaceutical products Heers · balance sheet €16.4m
- Pharmacie populaire La Sauvegarde Retail sale of pharmaceutical products Soumagne · balance sheet €5.64m
- Pharmacies Servais Retail sale of pharmaceutical products Wavre · balance sheet €28.6m
- M.D.D. Pharma Retail sale of pharmaceutical products Wavre · balance sheet €12.2m
- Biopharm Retail sale of pharmaceutical products Kortenberg · balance sheet €12.0m
- Apotheek Bytebier-Van Antwerpen Retail sale of pharmaceutical products Aartselaar · balance sheet €1.79m
Frequently asked questions about AFS
What is the revenue of AFS?
According to the 2025 annual accounts filed with the NBB, the revenue of AFS amounts to 9,024,957 €.
What is the VAT number of AFS?
In Belgium, the VAT number is the company number prefixed with BE: BE0406383082 for AFS, if the company is VAT-registered. Its company number (CBE) is 0406.383.082.
Where is the registered office of AFS?
According to the CBE register, the registered office of AFS is in 2600 Antwerp.
What is the equity of AFS?
At the close of the 2025 financial year, the equity of AFS amounts to 10,815,475 €, a solvency of 49.2% of total assets.
How many people work at AFS?
36.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages AFS?
The register lists 9 active mandates at AFS. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AFS
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →